Dr. Helia Farrokhzad, MD

Dr. Farrokhzad practices at Sanford Thief River Falls Medical Center in Thief River Falls, Minnesota, part of Sanford Health.

Dr. Farrokhzad's NPI, 1508215344, was assigned on June 10, 2016. Dr. Farrokhzad holds Minnesota license 65390.

Dr. Farrokhzad's primary practice is Sanford Thief River Falls Medical Center, at 3001 Sanford Parkway, Thief River Falls, MN 56701 in Pennington County. The practice phone is (218) 683-2652.

Dr. Farrokhzad's primary practice is Sanford Thief River Falls Medical Center in Thief River Falls, Minnesota, part of Sanford Health. Dr. Farrokhzad is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford Mayville Clinic. Dmand AI also links Dr. Farrokhzad to 3 more hospitals, 2 skilled nursing facilities, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farrokhzad practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Farrokhzad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Farrokhzad is licensed in Minnesota.

CMS data shows 407 Medicare services from Dr. Farrokhzad across 4 procedure codes in 2024, for 212 Medicare patients. Medicare paid $20,091 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Farrokhzad in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farrokhzad's median patient age at 76, with 71% women.

In 2024, Dr. Farrokhzad wrote 8,223 Medicare Part D claims for 573 patients. 88% of them were for generic drugs. CMS names the drug for 7,488 of them, across 107 drugs with 11 or more claims each, at $404,182 in total drug cost. In 2023, CMS named 13,705 claims across 158 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Farrokhzad for performance year 2024, reported as part of a group. Dr. Farrokhzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Farrokhzad from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Edwards Lifesciences Corporation paid the most, $13.